1 / 18

UK Renal Registry 16th Annual Report - Transplant Outcomes Analysis 2005-2012

Explore transplant outcomes from 2005 to 2012 in the UK Renal Registry's 16th Annual Report. Data includes eGFR, haemoglobin levels, blood pressure, and causes of death for prevalent patients.

jwilbur
Download Presentation

UK Renal Registry 16th Annual Report - Transplant Outcomes Analysis 2005-2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2012 UK Renal Registry 16th Annual Report

  2. Figure 3.2. Median eGFR in prevalent transplant patients by centre on 31/12/2012 UK Renal Registry 16th Annual Report

  3. Figure 3.3. Percentage of prevalent transplant patients by centre on 31/12/2012 with eGFR <30 ml/min/1.73 m2 UK Renal Registry 16th Annual Report

  4. Figure 3.4. Funnel plot of percentage of prevalent transplant patients with eGFR <30 ml/min/1.73 m2 by centre size on 31/12/2012 UK Renal Registry 16th Annual Report

  5. Figure 3.5a. Median eGFR one year post-live donor transplant by transplant centre 2005–2011 UK Renal Registry 16th Annual Report

  6. Figure 3.5b. Median eGFR one year post-brainstem death donor transplant by transplant centre 2005–2011 UK Renal Registry 16th Annual Report

  7. Figure 3.5c. Median eGFR one year post-circulatory death donor transplant by transplant centre 2005–2011 UK Renal Registry 16th Annual Report

  8. Figure 3.6a. Median eGFR one year post-live donor transplant by year of transplantation 2005–2011 UK Renal Registry 16th Annual Report

  9. Figure 3.6b. Median eGFR one year post-brainstem death donor transplant by year of transplantation 2005–2011 UK Renal Registry 16th Annual Report

  10. Figure 3.6c. Median eGFR one year post-circulatory death donor transplant by year of transplantation 2005–2011 UK Renal Registry 16th Annual Report

  11. Figure 3.7a. Median haemoglobin for prevalent transplant patients with eGFR >30 ml/min/1.73m2 by centre on 31/12/2012 UK Renal Registry 16th Annual Report

  12. Figure 3.7b. Median haemoglobin for prevalent transplant patients with eGFR <30 ml/min/1.73 m2 by centre on 31/12/2012 UK Renal Registry 16th Annual Report

  13. Figure 3.8a. Percentage of prevalent transplant patients with eGFR >30 ml/min/1.73m2 achieving haemoglobin >100 g/L by centre on 31/12/2012 UK Renal Registry 16th Annual Report

  14. Figure 3.8b. Percentage of prevalent transplant patients with eGFR <30 ml/min/1.73 m2 achieving haemoglobin >100 g/L by centre on 31/12/2012 UK Renal Registry 16th Annual Report

  15. Figure 3.9. Funnel plot of percentage of prevalent transplant patients with haemoglobin <100 g/L by centre size on 31/12/2012 UK Renal Registry 16th Annual Report

  16. Figure 3.10a. Percentage of prevalent transplant patients with eGFR >30 ml/min/1.73m2 achieving blood pressure of <130/80 mmHg by centre on 31/12/2012 UK Renal Registry 16th Annual Report

  17. Figure 3.10b. Percentage of prevalent transplant patients with eGFR <30 ml/min/1.73m2 achieving blood pressure of <130/80 mmHg by centre on 31/12/2012 UK Renal Registry 16th Annual Report

  18. Figure 3.11. Cause of death by modality for prevalent patients on 1/1/2012 UK Renal Registry 16th Annual Report

More Related